Yavuz Emre Parlar

Dr. Yavuz Emre Parlar


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2023 in World Journal of Hepatology
Verified
Journal Article
Open access
YPYavuz Emre Parlar
Yavuz Emre Parlar
SASefika Nur Ayar
Sefika Nur Ayar
DCDeniz Cagdas
Deniz Cagdas
YBYasemin H Balaban
Yasemin H Balaban
Liver immunity, autoimmunity, and inborn errors of immunity

31 July 2023 in Surgical Laparoscopy, Endoscopy & Percutaneous Techniques
Verified
Journal Article
Closed access
YPYavuz Emre Parlar
Yavuz Emre Parlar
FMFuad Mustafayev
Fuad Mustafayev
CVCavanşir Vahabov
Cavanşir Vahabov
TŞTevhide Şahin
Tevhide Şahin
SISabir İsRafilov
Sabir İsRafilov
BSBülent Sivri
Bülent Sivri
Background: The rate of using antithrombotic (AT) drugs is frequently high in patients who require percutaneous endoscopic gastrostomy (PEG). The aim of this study was to determine whether the risk of bleeding after PEG increases in patients whose AT drugs were discontinued according to the European Society Gastrointestinal Endoscopy guidelines (warfarin for 5 d, low molecular weight heparin for 24 h, DOAC for 3 d, and clopidogrel for 7 d). Patients and Methods: Data from 243 patients, who underwent PEG tube placement and received AT drugs and 206 patients who did not between 2018 and 2021 in our hospital, were evaluated retrospectively. Bleeding was defined as requiring blood transfusion, hematemesis and/or melena, decreased hemoglobin, or bleeding from PEG. Results: A total of 243 (54.1%) patients (121 (49.7%), women, mean age (75.7 y) who underwent PEG and received AT drugs, and 206 (45.9%) patients who did not (92 (44.6%), women, mean age (63.15 y). The medications and bleeding rates of the patients are given in Table 1. The rate of bleeding in patients using AT medication was significantly higher than that in patients not using medication (Table 2) (P = 0.007). When the AT drugs were compared among themselves, the bleeding risk did not differ. Bleeding was detected in 10 patients with bleeding from the PEG tube in 4 with melena. Bleeding detected in 14 patients was controlled with adrenaline injections. None of the patients required transfusion or repeat endoscopies. No bleeding-related deaths were reported. Conclusion: Even if patients receiving AT drugs are treated as recommended by international guidelines, it should be kept in mind that bleeding may occur after PEG, and the patients should be followed accordingly.

1 January 2022 in Hepatology Forum
Verified
Journal Article
Open access
PDF file
YPYavuz Emre Parlar
Yavuz Emre Parlar
HBhatice yasemin Balaban
hatice yasemin Balaban
UMUmit Yavuz Malkan
Umit Yavuz Malkan
EDErdogan Deniz
Erdogan Deniz
FUFatma Rukiye Uysal
Fatma Rukiye Uysal
D-penicillamine therapy is considered an effective and safe treatment for Wilson’s disease. Except for one experimental study, there has been no report in the literature about the development of disseminated intravascular coagulation (DIC) with the use of the drug. A 24-year-old female patient with Wilson’s disease, followed up with zinc and D-penicillamine treatment, was admitted to the emergency service because of oral mucosal bleeding and lethargy. Initial laboratory tests showed hemoglobin 7.1 g/dL (11.7-15.5), platelet 24×103 µL-1 (159-388), total bilirubin 18 mg/dL (0.3-1.2), direct bilirubin 9.8 mg/dL (0-0.2), INR >10 (0.8-1.2), aPTT 64.5 s (22.5-32), fibrinogen 23 mg/dL (180-350), and factor 8 26.4% (70-150). Melena, hematemesis, and hematochezia were not present, and no active bleeding focus was detected on endoscopic evaluation. Upon meeting the DIC criteria, the patient underwent plasma exchange four times for the treatment of acute-on-chronic liver failure. Haemocomplettan-P, cryoprecipitate replacements were made as a supportive treatment for DIC. As the clinical bleeding continued despite plasma exchanges and factor replacement treatment, D-penicillamine was switched to trientine (1250 mg/day). After this change, the mucosal bleeding stopped, and DIC parameters improved. We suggest that if hemorrhagic complications develop on D-penicillamine treatment, the possibility of DIC induced by D-penicillamine activating the fibrinolysis should also be considered.

21 April 2026 in Akademik Gastroenteroloji Dergisi
Verified
Journal Article
Closed access
YPYavuz Emre Parlar
Yavuz Emre Parlar
MCMehmet Coşkun
Mehmet Coşkun
BOBengi Ozturk
Bengi Ozturk
Backgorund and Aims: Acute pancreatitis ranges from mild disease to severe forms associated with organ failure and mortality. Early risk stratification is essential, yet current scoring systems may not fully reflect early metabolic alterations. While hypocalcemia is a recognized severity marker, the prognostic role of phosphorus remains unclear. This study evaluated whether early phosphorus-to-calcium ratio changes within 48 hours predict disease severity in acute pancreatitis. Materials and Method: This retrospective single-center study included adults hospitalized with acute pancreatitis between January 2023 and December 2025. Phosphorus-to-calcium ratio was calculated from routinely recorded serum phosphorus and calcium levels at admission, 24, and 48 hours. Severity was defined according to the Revised Atlanta Classification. Multivariable logistic regression and receiver operating characteristic analyses were performed. Results: A total of 182 patients were included [mean age 56.8 ± 15.9 years; 100 male (54.9%)]. Mild acute pancreatitis occurred in 140 patients (76.9%), moderately severe in 32 (17.6%), and severe in 10 (5.5%). Persistent organ failure occurred in 12 (6.6%), intensive care unit admission in 14 (7.7%), and in-hospital mortality in 3 patients (1.6%). Phosphorus-to-calcium ratio values increased during the first 48 hours and were higher in moderate-to-severe/severe disease. After adjustment for age, creatinine, C-reactive protein level, and clinical severity score, the 48-hour change in the phosphorus-to-calcium ratio remained independently associated with severity (Odds ratio 1.64, 95% confidence interval 1.14 - 2.36, p = 0.008). Conclusion: Early phosphorus-to-calcium ratio dynamics may serve as a simple adjunct biomarker to existing clinical scores for predicting severity in acute pancreatitis.


1 November 2025 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
YPYavuz Emre Parlar
Yavuz Emre Parlar
ZŞZahide Şimşek
Zahide Şimşek
Background: Barrett’s esophagus (BE) is a premalignant condition resulting from chronic gastroesophageal reflux disease (GERD), associated with increased risk of esophageal adenocarcinoma. Endoscopic identification of BE remains imperfect without histological confirmation. This study evaluates the diagnostic accuracy of endoscopy in detecting BE and identifies its associated factors using data from a large cohort of dyspeptic patients. Methods: In this retrospective study, we reviewed 41,268 adults undergoing upper gastrointestinal endoscopy for dyspeptic symptoms between 2014 and 2018. Among them, 840 had suspected BE. Biopsies were obtained per the Seattle protocol and assessed for intestinal metaplasia by expert pathologists. Clinical and endoscopic features and Helicobacter pylori status were analyzed. Results: Histological confirmation was achieved in 423 of 840 patients (50.4%). Short-segment BE comprised 97.4% of cases. Multivariate analysis identified age≥50 years, male sex, presence of hiatal hernia, and absence of H. pylori as independent predictors of histologically confirmed BE (P<0.05 for all). H. pylori prevalence was significantly lower in BE patients (26.2%) compared to non-BE patients (47.7%). Conclusion: Endoscopic suspicion alone significantly overestimates BE prevalence, particularly for short-segment BE. Systematic biopsies remain essential for accurate diagnosis. The inverse association between H. pylori and BE suggests that H. pylori infection may be linked with a lower prevalence of BE. Targeted screening strategies are needed, especially in high-risk populations.